Trial Profile
A Pilot Study of Efficacy and Tolerability of Levetiracetam Monotherapy in Subjects With Childhood Absence Epilepsy.
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 30 Oct 2014
Price :
$35
*
At a glance
- Drugs Levetiracetam (Primary)
- Indications Absence epilepsy
- Focus Therapeutic Use
- Acronyms KeppraCAE
- 27 Jul 2011 Actual end date (Dec 2007) added as reported by ClinicalTrials.gov.
- 27 Jul 2011 Actual initiation date (Dec 2006) added as reported by ClinicalTrials.gov.
- 17 Jul 2008 New trial record.